|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sympathetic nervous system activation and heart failure:Current state of evidence and the pathophysiology in the light of novel biomarkers显示文摘Heart failure(HF)is a complex clinical syndrome characterized by the activation of at least several neurohumoral pathways that have a common role in maintaining cardiac output and adequate perfusion pressure of target organs and tissues.The sympathetic nervous system(SNS)is upregulated in HF as evident in dysfunctional baroreceptor and chemoreceptor reflexes,circulating and neuronal catecholamine spillover,attenuated parasympathetic response,and augmented sympathetic outflow to the heart,kidneys and skeletal muscles.When these sympathoexcitatory effects on the cardiovascular system are sustained chronically they initiate the vicious circle of HF progression and become associated with cardiomyocyte apoptosis,maladaptive ventricular and vascular remodeling,arrhythmogenesis,and poor prognosis in patients with HF.These detrimental effects of SNS activity on outcomes in HF warrant adequate diagnostic and treatment modalities.Therefore,this review summarizes basic physiological concepts about the interaction of SNS with the cardiovascular system and highlights key pathophysiological mechanisms of SNS derangement in HF.Finally,special emphasis in this review is placed on the integrative and up-to-date overview of diagnostic modalities such as SNS imaging methods and novel laboratory biomarkers that could aid in the assessment of the degree of SNS activation and provide reliable prognostic information among patients with HF. | Josip Anđelo Borovac Domenico D'Amario Josko Bozic Duska Glavas | 2020 | World Journal of Cardiology2020，12，8： | 14 |
| 2 | Endometrial cancer in women 40 years old or younger显示文摘 | Duska LR Garrett A Rueda BR | 2001 | Gynecol Oncol2001，83，2： | 1 |
| 3 | A pilot trial of TAC (paclitaxel,doxorubiein,and carboplatin)chemotherapy with filgastrim support followed by radiotherapy in patients with high-risk endometrial cancer显示文摘 | Duska LR Berkowitz R Matulonis U | 2005 | Gynecol Oncol2005，96，： | 1 |
| 4 | Parenterally administered dipep- tide alanyl-glutamine prevents worsening of insulin sensitivity in multi- pie-trauma patients显示文摘 | Bakalar B Duska F Pachl J | 2006 | Crit Care Med2006，34，38： | 1 |
| 5 | A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography显示文摘 | Bristow RE Duska LR Lambrou NC | | 0，，07： | 1 |
| 6 | Endometrial can- cer in women of 40 years old or younger 显示文摘 | Duska LR Carrett A Rueda BR | 2001 | Gynecol On- col2001，83，20： | 1 |
| 7 | A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography显示文摘 | Bristow RE Duska LR Lambrou NC | 2000 | Cancer2000，89，6： | 1 |
| 8 | Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix显示文摘 | Boruta D M Schorge J O Duska L A | 2001 | Gynecol Oncol2001，81，1： | 1 |
| 9 | An international series on abdominal radical trachelectomy: 101 patients and 28 pregnancies 显示文摘 | Wethington S L Cibula D Duska L R | 2012 | Int J Gynecol Cancer2012，22，7： | 1 |
| 10 | A pilot trial of TAC (paclitaxe,doxorubicin,and carboplatin) chemotherapy with filgastrim support followed by radiotherapy in patients with high-risk endometrial cancer显示文摘 | Duska LR Berkowitz R Matulonis U | 2005 | Gynecol Oncol2005，96，1： | 1 |
| 11 | Epithelial ovarian carcinoma in the reproductive age group显示文摘 | Duska LR Chang YC Flynn CE | | 0，，12： | 1 |
| 12 | Cervical cancer 2015 and beyond: A focus on innovati~,e treatments and attention to survivorship显示文摘 | Duska LR | 2015 | Clin Ther2015，，： | 1 |
| 13 | The role of cytoreductive surgery in the management of stage Ⅳ uterine papillary serous carcinoma显示文摘 | Bristow RE Duska LR Montz FJ | 2001 | Gynecol Oncol2001，81，1： | 1 |
| 14 | Improving quality of life in female cancer survivors: current status and future question显示文摘 | Duska LR Dizon OS | 2014 | Future Oncol2014，，6： | 1 |
| 15 | Multimodalitytherapy in early-stage neuroendocrine carcinoma of the uterinecervix显示文摘 | Boruta DM 2nd Schorge JO Duska LA | 2001 | Gynecol Oncol2001，81，1： | 1 |
| 16 | A model for predicting surgical outcome in patients with advanced Krukenberg carcinoma using computed tomography显示文摘 | Bristow RE Duska LR Lambrou NC | 2000 | Cancer2000，89，7： | 1 |
| 17 | A pilot trial of TAC ( paclitaxe, doxombicin, and carboplatin) chemo- therapy with filgastrim support followed by radiotherapy in patients with high - risk endometrial cancer 显示文摘 | Duska LR Berkowitz R Matulonis U | 2005 | Gynecol Oncol2005，96，1： | 1 |
| 18 | Severe gastrointesti nal complications in the era of image-guided high-dose-rate intra cavitary brachytherapy for cervical cancer显示文摘 | Trifiletti DM Tyler Watkins W Duska L | 2015 | Clin Ther2015，37，： | 1 |
| 19 | Endometrial canc- er in women 40 years old or younger显示文摘 | Duska LR Garrett A Rueda BR | 2001 | Gynecol Oncol2001，83，2： | 1 |
| 20 | Borderline tumors of the ovap:correlation of frozen and pernlanent histopathologic diagnosis显示文摘 | Houck K Nikrui N Duska L | 2000 | Obstet Gynecol2000，95，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员